Document Detail

Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNs.
MedLine Citation:
PMID:  17145575     Owner:  NLM     Status:  MEDLINE    
Previous studies have detected bcl2 and c-myc upregulated in Hela cells. In this study, we investigated the effect on apoptosis of Hela cells by combining transfection of bcl2 and c-myc antisense oligonucleotides(ASODNs), and to explore the relationship between combining gene transfection and radiosensitivity of Hela cells, furthermore, to seek a new method to enhance the radiosensitivity of tumor cells. ASODNs of bcl2 and c-myc coated with cationic liposomes were designed and synthesized and transfected to Hela cells. The expressions of BCL2 and C-MYC were assessed by immunohistochemistry (IHC) staining and flow cytometry (FCM), and the induced-apoptosis phenomenon of Hela cells transfected with bcl2 ASODN or c-myc ASODN was observed by Giemsa Staining, DNA Ladder and FCM. Irradiation was performed on ASODNs transfected cells, then the radiosensitivity, biological reaction and cell proliferation of the transfected cells were investigated by cellular clone formation analysis, MTT assay and FCM. Both bcl2 and c-myc ASODNs could partially inhibit the growth of Hela cells by reducing the expression of bcl2 and c-myc (p < 0.05). The apoptosis rate of Hela cells treated with bcl2 ASODN was 6.60 +/- 0.70%, c-myc ASODN 10.29 +/- 0.66%, bcl2 + c-myc ASODNs 11.83 +/- 0.57 %, which were much higher than that of control 1.79 +/- 0.19%(p < 0.05). The sensitivity enhancement ratio(SER) of Hela cells transfected with bcl2 ASODN,c-myc ASODN and bcl2 + c-myc ASODNs was 1.20, 1.53 and 2.18 respectively. Combining transfection of bcl2 and c-myc ASODN could more effectively induce apoptosis of Hela cells, which subsequently enhanced radiosensitivity of Hela cells. Furthermore, combining transfection ASODNs of apoptosis-inhibiting genes or oncogenes followed radiotherapy to malignant tumor cells might be a new potential strategy.
Rongrong Li; Yufeng Cheng; Chengjin Gao
Related Documents :
13385405 - Growth characteristics of tubercle bacilli and certain other mycobacteria in hela cells.
20155925 - Nanoparticle-based biocompatible and long-life marker for lysosome labeling and tracking.
360375 - Penetration of antimicrobials into tissue culture cells and leucocytes.
18342635 - Photosensitizer effects on cancerous cells: a combined study using synchrotron infrared...
20599265 - Rapid construction of mechanically- confined multi- cellular structures using dendrimer...
25482935 - Increasing cisplatin sensitivity by schedule-dependent inhibition of akt and chk1.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bulletin du cancer     Volume:  93     ISSN:  1769-6917     ISO Abbreviation:  Bull Cancer     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-12-05     Completed Date:  2006-12-18     Revised Date:  2011-04-05    
Medline Journal Info:
Nlm Unique ID:  0072416     Medline TA:  Bull Cancer     Country:  France    
Other Details:
Languages:  eng     Pagination:  E119-25     Citation Subset:  IM    
Department of Radiology, Jinshan Hospital, Fudan University, 200540 Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Apoptosis / genetics
Cell Survival
Culture Media
Gene Expression
Genes, bcl-2 / genetics*
Genes, myc / genetics*
Hela Cells / metabolism,  radiation effects*
Oligonucleotides, Antisense / genetics*,  therapeutic use
Proto-Oncogene Proteins c-bcl-2 / genetics,  metabolism
Proto-Oncogene Proteins c-myc / genetics,  metabolism
Radiation Tolerance / genetics*
Transfection / methods*
Reg. No./Substance:
0/Culture Media; 0/Oligonucleotides, Antisense; 0/Proto-Oncogene Proteins c-bcl-2; 0/Proto-Oncogene Proteins c-myc

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma.
Next Document:  [Neoadjuvant chemotherapy in non small cell lung cancer].